An interventional study of stent in Colorectal Obstruction and Left Colonic Adenocarcinoma, sponsored by University Hospital, Montpellier. Terminated. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2007-08-09.
Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Treatment
To evaluate wether colorectal stenting carry a significant clinical advantage
Randomized controlled comparison between stents and primary surgery in obstructive left colonic obstructive carcinoma outside palliative situations.
2,004 studies on the registry are indexed under Adenocarcinoma; 374 are open to participants now.
This study's enrollment of 70 is above the median of 45 across 1,553 interventional studies indexed under Adenocarcinoma.
Browse Adenocarcinoma studies →University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
primary surgery group
Procedure: stent
stent placement for colorectal cancer obstruction
Also known as: self-expending metallic stents
number of stoma in each group
Time frame: within the first 6 month(plus or minus 1 month) after surgery
mortality in each group
Time frame: within the first 6 month (plus or minus 1 month) after surgery
complications
Time frame: within the first 6 month (plus or minus 1 month) after surgery
number of procedures
Time frame: within the first 6 month (plus or minus 1 month) after surgery
length of stay
Time frame: within the first 6 month (plus or minus 1 month) after surgery
No study locations are listed for this record.
This study is terminated, as verified in Aug 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier